Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Costs topic
No spam. Unsubscribe anytime.
Health‑benefits brokers tell West Orange board medical and drug costs are surging
Summary
Health‑benefits brokers told the West Orange Board that medical costs are rising roughly 12% and prescription costs (driven by specialty drugs) over 20%, heightening the district’s fiscal pressures and contributing to a $14 million shortfall the superintendent described.
Get email alerts on the Healthcare Costs topic
No spam. Unsubscribe anytime.
Brown & Brown brokers briefed the West Orange Board of Education on April 20 about statewide health‑insurance market trends that will affect school districts. Mike Morrow, vice president at Brown & Brown, told the board the upcoming fiscal year promises “the most challenging health‑insurance year we’ve had in New Jersey for school districts in over 25 years,” citing a roughly 12% increase in medical claims trend and more than 20% increases in prescription spending.
Jim Finn, senior vice president at Brown & Brown, attributed pressures to several factors: hospital reimbursement demands, longer‑term public‑health effects from the pandemic, and rapid uptake of high‑cost specialty medications (including GLP‑1 weight‑loss drugs). The brokers also discussed the mechanics of different purchasing structures — fully insured carriers, pooled self‑insurance funds and self‑insured employer models — and explained how prescription rebate dollars are treated differently depending on the sponsoring entity.
The presentation framed the health‑benefits picture as a major driver of the district’s fiscal difficulties; later in the meeting Superintendent Moore said health‑benefit increases are a central part of the $14 million shortfall. The district’s participation in the Schools’ Health Insurance Fund provides some pooling advantages, but brokers cautioned that many risk bearers are projecting double‑digit increases for the coming year.
Board members asked detailed questions about fund capitalization and rebate flows; brokers said the pooled fund had over $100 million in cash but that participant rates would still need notable increases to remain solvent. The presentation and questions underscored how external market trends exacerbate local budget choices and timelines.

